Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02229149
Status:
TERMINATED
Last Update Posted:
2022-12-02
First Post:
2014-08-27
Brief Title:
Phase 2 Study of Standard Chemotherapy With Trastuzumab Plus or Minus Pertuzumab for Pre-treated Metastatic Breast Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Organization Data
Organization:
US Oncology Research
Class:
INDUSTRY
Study ID:
13011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
US Oncology Research
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |